抗体药物在肿瘤治疗中的应用与进展

秦雨婷, 泮明珠, 张娟 - 药学进展, 2024 - pps.cpu.edu.cn
单克隆抗体药物以其特异性高, 亲和力强, 血清半衰期长等优点在肿瘤治疗领域得到广泛应用.
基于母体单克隆抗体而设计的双特异性抗体, 抗体片段, 抗体药物偶联物等将抗体类药物的开发 …

Antibody-drug conjugates targeting EGFR ligand Epiregulin inhibit colorectal tumor growth irrespective of RAS mutational status

J Jacob, Y Anami, P High, Z Liang, S Subramanian… - bioRxiv, 2024 - biorxiv.org
Purpose: The EGFR ligand, epiregulin (EREG), is highly expressed in colorectal cancers
(CRCs) and a biomarker for predicting benefit in RAS wildtype patients receiving EGFR …

Light Chain Q166C Mutation Permits One‐step Site Specific Conjugation on Monoclonal Antibodies

M Li, C Song, J Li, J Min, L Cao, L Wang… - ChemBioChem, 2023 - Wiley Online Library
Engineered cysteines are frequently used for site‐specific conjugation in antibody‐drug
conjugate (ADC) development. When cysteine‐engineered mAbs are produced in the cell …

Development of new chemical strategies for the site selective conjugation of native proteins

V Vaur - 2023 - theses.hal.science
The development of chemical methods for the site-selective modification of proteins have
been widely investigated for the past decades, especially in the therapeutic field. Because of …

Resumen de tesis. Nuevas estrategias frente a receptores de la familia ErbB/HER y sus ligandos en cáncer

I Romero Pérez - 2023 - gredos.usal.es
[ES] La familia de receptores tirosina quinasa ErbB/HER y sus ligandos juegan un papel
fundamental en las vías de señalización implicadas en la proliferación, migración y …

Exploring drug sensitivity and Enhertu resistance in breast cancer tissue using ex vivo cultures.

ET Degnov - 2023 - duo.uio.no
Ex vivo tumor tissue cultures, such as organoids or explants, hold promise as a drug
screening platform for functional precision diagnostics. In this project, we have employed …

[引用][C] 링커기술을중심으로한항체-약물복합체기술개요

정상전 - BT NEWS, 2023 - dbpia.co.kr
항체-약물복합체 (Antibody-drug Conjugate, ADC) 는 강력한 세포독성 항암제를 암세포
특이적인 항체에 접합하여 암세포 내부로 전달함으로써 정상세포 보다는 암세포에선택적인 …